Developer docs
API playgroundTry for free, no card

Search company profiles

Nuvo Group

Full company profile

uuid0004y59

Namestring
Nuvo Group
Legal namestring
Nuvo Intl Group Inc.
Websiteurl
nuvocares.com
Company typeenum
Private
Founded yearint
2007
Descriptiontext

Nuvo Group (NASDAQ: NUVO) is a digital health company headquartered in Tel Aviv, Israel with U.S. operations in Aventura, Florida. The company develops the INVU by Nuvo platform — a prescription-based, FDA-cleared (K210025) and CE-marked system comprising a wearable sensor band with multiple detachable sensors, a patient-facing mobile application (iOS/Android), a cloud-based data processing platform, and a clinician web portal (INVU Pro) with EMR integration via Nuvo-supplied APIs. The platform enables expectant mothers — particularly those with high-risk pregnancies or limited obstetric access — to conduct clinically validated non-stress tests and continuous fetal-maternal heart-rate monitoring at home, with data transmitted to healthcare providers for remote review.

The company's core technology captures native fetal and maternal ECG and phonocardiography alongside uterine activity through a novel cardiac-derived algorithm published in the American Journal of Obstetrics and Gynecology. Nuvo has accumulated what it describes as the largest real-world longitudinal dataset of synchronized maternal-fetal physiological signals (350,000+ minutes across 25,000+ sessions), IRB-approved for retrospective analysis, which underpins its AI roadmap for early-complication detection, predictive analytics, and population-health tools developed in partnership with Sheba Medical Center's ARC innovation arm.

Nuvo generates revenue primarily through a subscription/lease model in which healthcare providers lease the INVU monitoring kit and prescribe it to expectant mothers, with sessions billed through providers and payers. Go-to-market relies on enterprise field sales to OB/GYNs and maternal-fetal medicine specialists, channel partnerships with telehealth and virtual-hospital providers (Ouma Health, Sheba Beyond), and direct deployments into rural hospitals (Golden Valley Memorial Healthcare). A future revenue stream from data licensing of the AI-ready pregnancy dataset is contemplated but not yet commercialized. Customer segments span pregnant women (especially high-risk), healthcare providers, payers/employers, and rural health systems addressing maternity-care deserts.

Short descriptiontext

Nuvo Group (NASDAQ: NUVO) develops the FDA-cleared INVU wearable platform for remote, continuous fetal-maternal monitoring, serving OB/GYNs, maternal-fetal medicine specialists, and expectant mothers — particularly in maternity-care deserts — through a healthcare-provider subscription/lease model with EMR-integrated clinician tools.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersAventura, United States
HQ citystring
Aventura
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
remote pregnancy monitoring, fetal heart rate monitoring, maternal health technology, wearable medical devices, telehealth monitoring
Industry3 codes
PRIMARYHLAHACAF
Maternal, Fetal & Neonatal Monitoring (CTG, Infant Wearables)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Patient Monitoring, Wearables & Remote Diagnostics
SECONDARYHLACAPAG
Maternal, Neonatal & Pediatric Remote Monitoring
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring
SECONDARYHLALAHAC
Pregnancy & Prenatal Care Telehealth (OB tele-visits, prenatal monitoring)
Healthcare & Life Sciences/Telehealth Platforms/Women’s & Family Health Telehealth Platforms (fertility, pregnancy, pediatrics)
NAICS code1 code
  • Surgical Appliance and Supplies Manufacturing339113
SIC code1 code
  • Surgical & Medical Instruments & Apparatus3841
Product category
Remote Pregnancy Monitoring
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model3 records
1Device Leasing
TypeSubscription Recurring
Description

INVU monitoring kit is leased through healthcare providers. The wearable sensor band is provided to expectant mothers via prescription through their healthcare provider, with the provider leasing the system.

prnewswire.com
2Remote Monitoring Services
TypeSubscription Recurring
Description

Revenue generated from remote fetal monitoring sessions conducted through the INVU platform, billed through healthcare providers and payers.

nuvocares.com
3Data Licensing (Future)
TypeData Monetisation
Description

Potential future revenue from the large-scale pregnancy dataset for research and AI development purposes.

businesswire.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Operations, Marketing or Sales, Supply Chain
Pricing details1 tier
1Healthcare provider leasing model
ModelSubscriptionBilling cadenceMonthly
Notes

INVU is offered as a lease through healthcare providers. No specific pricing is publicly available - the system is prescription-based and billed through healthcare providers and insurance.

prnewswire.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 2 records shown
1INVU
Description

FDA-cleared remote pregnancy monitoring wearable platform with sensor band, mobile app, and cloud-based data capture and visualization for fetal and maternal health monitoring.

nuvocares.com
+1 more record
Core offering1 text field

Nuvo Group develops and sells the INVU by Nuvo platform, the first and only FDA-cleared wearable system for remote, continuous fetal-maternal monitoring. The platform consists of a proprietary sensor band worn around the expectant mother's belly, a patient-facing mobile app (iOS/Android), the INVU Pro clinician web portal, and a cloud-based data processing platform with EMR integration, enabling pregnant women to perform clinically validated non-stress tests at home or work while clinicians review the data remotely.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • One patient maintained pregnancy from week 32 to week 37 when doctors expected induction at week 34, using remote monitoring instead of hospital admission
+2 more records
Product overview1 text field

Nuvo Group offers the INVU by Nuvo™ platform — a comprehensive remote pregnancy monitoring solution comprised of an FDA-cleared wearable sensor band, a patient-facing mobile app (available on iOS and Android), a clinician web portal (INVU Pro), and a proprietary cloud-based data processing platform. The system enables expectant mothers to perform clinically validated non-stress tests (NSTs) and fetal-maternal heart rate monitoring at home or work, with data transmitted to healthcare providers for review. Nuvo also offers an AI-ready longitudinal pregnancy dataset built from INVU monitoring sessions, and the INVU Pro clinician portal enables prescription management, session scheduling, EMR integration, and clinical data review. A recently launched RHTP Application Support Package helps rural providers pursue federal funding for INVU deployment.

Product and service5 records
1INVU Wearable Sensor Band
CategoryRemote Pregnancy Monitoring Hardware
Description

FDA-cleared wearable sensor band worn around the expectant mother's belly that captures fetal ECG, fetal phonocardiography, maternal ECG, maternal phonocardiography, and uterine activity data during remote monitoring sessions; provided to expectant mothers via prescription through healthcare providers.

2INVU Mobile App
CategoryPatient Mobile Application
Description

Patient-facing iOS and Android mobile application that connects to the INVU sensor band via Bluetooth, guides self-administered monitoring sessions, delivers self-guided training, allows patients to chat with support, and access monitoring results and session data.

3INVU Pro Clinician Portal
CategoryClinician Software Portal
Description

Web-based portal for healthcare providers to prescribe the INVU system, schedule remote monitoring sessions, review and interpret monitoring data transmitted from patient devices, and integrate session data into the provider's EMR.

4INVU Cloud Platform
CategoryCloud Data Platform
Description

Proprietary cloud-based platform that captures, analyzes, and transmits patient data from the INVU sensor band, supports the monitoring workflow for patients and clinicians, stores physiological data in a data lake, and enables integration with EMR systems via Nuvo-supplied APIs.

5INVU AI-Ready Pregnancy Dataset
CategoryClinical Data Asset
Description

Large-scale real-world longitudinal dataset of synchronized maternal and fetal physiological signals built from INVU monitoring sessions, combining fetal ECG and phonocardiography with maternal ECG and phonocardiography collected in clinical and home settings; IRB-approved for retrospective analyses and AI model training.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership8 partners
1TLC Perinatal
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2026-03-23
Description

TLC Perinatal, a leading maternal-fetal medicine practice in the DC-Maryland region, adopted INVU for on-demand fetal monitoring. The practice provides pregnant women access to remote non-stress tests connected with their healthcare team for clinical review, supporting high-risk and proactive care.

prnewswire.com
2Golden Valley Memorial Healthcare (GVMH)
Strategic tierStrategicTypeChannel Partner/ Reseller/ DistributorAnnounced on2026-03-16
Description

Golden Valley Memorial Healthcare deployed INVU to improve maternal health in rural Missouri, addressing the challenge of limited access to obstetric care in maternity care deserts. GVMH is one of the first regional hospitals to deploy this technology to enhance prenatal care for high-risk pregnancies.

prnewswire.com
Strategic tierStrategicTypeStrategic or Co-development PartnerAnnounced on2025-09-16
Description

Philips teams up with Nuvo to broaden maternity care access in rural areas with remote monitoring technology, combining Philips' healthcare technology portfolio with Nuvo's INVU platform.

Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2025-09-15
Description

Nuvo partnered with MFM Associates to offer remote Non-Stress Tests (NSTs) in New York City, expanding access to INVU monitoring through maternal-fetal medicine specialists.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-02-24
Description

ARC and Nuvo are developing advanced AI-driven solutions that enhance clinical decision-making, improve early detection of pregnancy complications, and redefine continuous pregnancy monitoring. The collaboration will create AI-based modules for clinical decision-support tools and population health analysis to improve prenatal care quality.

Strategic tierStrategicTypeStrategic or Co-development PartnerAnnounced on2023-12-14
Description

Nuvo partnered with Georgia State University for an NIH-funded multisite study titled 'Advancing understanding of racism-related health disparities beginning before birth.' The study utilizes INVU to research how racism-related stressors impact maternal and fetal health among 400 Black and Latina women in their third trimester.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-12-11
Description

Nuvo partnered with Sheba Beyond, one of the world's first virtual hospitals, to transform care for high-risk pregnant patients. The partnership accelerated during wartime Israel to de-hospitalize high-risk inpatients while maintaining exceptional care. Sheba Beyond has been utilizing INVU for over a year to monitor pregnant patients remotely, with benefits including clinical accuracy, resource optimization, and improved patient outcomes.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-12-13
Description

Nuvo and Ouma partnered to deliver the world's first telehealth and remote monitoring solution for pregnancy care. The joint solution combines Ouma's 24/7/365 maternity telehealth clinical services with INVU's FDA-cleared remote fetal surveillance technology to provide equitable access to care, improve preventative care delivery, and reduce costs.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Bloomlife develops pregnancy-monitoring wearables that capture uterine and fetal signals for remote, at-home use. It is the closest direct competitor to Nuvo's INVU in the remote fetal-maternal wearable category.

TypeDirect peer
Description

HeraMED builds FDA-cleared remote fetal monitoring and pregnancy care solutions including the HeraBEAT handheld Doppler and SaaS maternal health platform. It competes directly with INVU in remote NST and home maternal monitoring.

TypeBroad incumbent
Description

Philips is a global incumbent in maternal-fetal monitoring (e.g., Avalon fetal monitors) and is also an INVU distribution partner. It competes with Nuvo in clinical fetal monitoring and could expand its own wearable roadmap.

TypeBroad incumbent
Description

GE HealthCare sells the Giraffe and Corometrics lines of fetal monitors used in hospitals and OB/MFM practices worldwide. It is a broad incumbent serving the same buyer base as INVU with established inpatient monitoring.

TypeBroad incumbent
Description

Mindray is a global medical device incumbent with a substantial patient and fetal monitoring portfolio sold into hospitals. It competes with Nuvo at the hospital procurement level even though it does not focus on remote at-home NST.

TypeEmerging player
Description

Owlet offers FDA-cleared baby monitors (e.g., Dream Sock) that track infant vital signs. While focused on the infant post-birth segment, Owlet competes for the same expectant-parent attention and connected-care wallet.

TypeEmerging player
Description

Babyscripts provides a digital maternity care platform combining remote patient monitoring, education, and risk stratification for payers and providers. It overlaps with Nuvo in the digital maternal RPM space, though its hardware is more limited.

TypeEmerging player
Description

Maven Clinic operates the largest virtual clinic for women's and family health, offering maternity care programs for employers and payers. It is a partial competitor via telehealth, especially through its overlap with Ouma Health.

TypeOthers
Description

Oura sells a consumer smart ring for continuous physiological monitoring (temperature, HR, sleep). It is thematically adjacent as a wearable health-data platform but does not currently monitor fetal signals or compete with INVU clinically.

TypeOthers
Description

iHealth Labs produces connected consumer health devices (BP monitors, glucose meters, thermometers) sold via retail and pharmacy channels. It is an adjacent connected-health hardware player but not a clinical fetal monitoring competitor.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
Yes

Docs URL, Description

Integration1 record

Each record includes

Title, Type, Description, Source

AI capability7 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles8 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds4 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors2 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Nuvo Group

Remote Pregnancy Monitoringnuvocares.com

Nuvo Group (NASDAQ: NUVO) develops the FDA-cleared INVU wearable platform for remote, continuous fetal-maternal monitoring, serving OB/GYNs, maternal-fetal medicine specialists, and expectant mothers — particularly in maternity-care deserts — through a healthcare-provider subscription/lease model with EMR-integrated clinician tools.

What Nuvo Group does

Nuvo Group (NASDAQ: NUVO) is a digital health company headquartered in Tel Aviv, Israel with U.S. operations in Aventura, Florida. The company develops the INVU by Nuvo platform — a prescription-based, FDA-cleared (K210025) and CE-marked system comprising a wearable sensor band with multiple detachable sensors, a patient-facing mobile application (iOS/Android), a cloud-based data processing platform, and a clinician web portal (INVU Pro) with EMR integration via Nuvo-supplied APIs. The platform enables expectant mothers — particularly those with high-risk pregnancies or limited obstetric access — to conduct clinically validated non-stress tests and continuous fetal-maternal heart-rate monitoring at home, with data transmitted to healthcare providers for remote review.

The company's core technology captures native fetal and maternal ECG and phonocardiography alongside uterine activity through a novel cardiac-derived algorithm published in the American Journal of Obstetrics and Gynecology. Nuvo has accumulated what it describes as the largest real-world longitudinal dataset of synchronized maternal-fetal physiological signals (350,000+ minutes across 25,000+ sessions), IRB-approved for retrospective analysis, which underpins its AI roadmap for early-complication detection, predictive analytics, and population-health tools developed in partnership with Sheba Medical Center's ARC innovation arm.

Nuvo generates revenue primarily through a subscription/lease model in which healthcare providers lease the INVU monitoring kit and prescribe it to expectant mothers, with sessions billed through providers and payers. Go-to-market relies on enterprise field sales to OB/GYNs and maternal-fetal medicine specialists, channel partnerships with telehealth and virtual-hospital providers (Ouma Health, Sheba Beyond), and direct deployments into rural hospitals (Golden Valley Memorial Healthcare). A future revenue stream from data licensing of the AI-ready pregnancy dataset is contemplated but not yet commercialized. Customer segments span pregnant women (especially high-risk), healthcare providers, payers/employers, and rural health systems addressing maternity-care deserts.

Nuvo Group firmographics

Firmographics
Name
Nuvo Group
Legal name
Nuvo Intl Group Inc.
Website
https://nuvocares.com
Company type
Private
Founded year
2007
Operating status
Operating
Headcount range
11–50 employees
Short description
Nuvo Group (NASDAQ: NUVO) develops the FDA-cleared INVU wearable platform for remote, continuous fetal-maternal monitoring, serving OB/GYNs, maternal-fetal medicine specialists, and expectant mothers — particularly in maternity-care deserts — through a healthcare-provider subscription/lease model with EMR-integrated clinician tools.
Ownership category
akta.pro rank

Nuvo Group industry classification

Industry
Product category
Remote Pregnancy Monitoring
NAICS
Surgical Appliance and Supplies Manufacturing (339113)
SIC
Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLAHACAF
Maternal, Fetal & Neonatal Monitoring (CTG, Infant Wearables)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Patient Monitoring, Wearables & Remote Diagnostics
SECONDARYHLACAPAG
Maternal, Neonatal & Pediatric Remote Monitoring
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring
SECONDARYHLALAHAC
Pregnancy & Prenatal Care Telehealth (OB tele-visits, prenatal monitoring)
Healthcare & Life Sciences/Telehealth Platforms/Women’s & Family Health Telehealth Platforms (fertility, pregnancy, pediatrics)

Keywords

  • Remote pregnancy monitoring
  • Fetal heart rate monitoring
  • Maternal health technology
  • Wearable medical devices
  • Telehealth monitoring

Where Nuvo Group is headquartered

Location

Headquarters

HQ city
Aventura
HQ country
United States
HQ region
North America

Offices2 records

Markets served

Nuvo Group business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Operations, Marketing or Sales, Supply Chain

Revenue model

  1. Device Leasing: INVU monitoring kit is leased through healthcare providers. The wearable sensor band is provided to expectant mothers via prescription through their healthcare provider, with the provider leasing the system.
  2. Remote Monitoring Services: Revenue generated from remote fetal monitoring sessions conducted through the INVU platform, billed through healthcare providers and payers.
  3. Data Licensing (Future): Potential future revenue from the large-scale pregnancy dataset for research and AI development purposes.

Pricing tiers

ModelBillingPrice
SubscriptionMonthlyHealthcare provider leasing model

Go-to-market motion3 records

Distribution channels5 records

Marketing channels6 records

Nuvo Group product offering

Product offering

Core offering

Nuvo Group develops and sells the INVU by Nuvo platform, the first and only FDA-cleared wearable system for remote, continuous fetal-maternal monitoring. The platform consists of a proprietary sensor band worn around the expectant mother's belly, a patient-facing mobile app (iOS/Android), the INVU Pro clinician web portal, and a cloud-based data processing platform with EMR integration, enabling pregnant women to perform clinically validated non-stress tests at home or work while clinicians review the data remotely.

Product overview

Nuvo Group offers the INVU by Nuvo™ platform — a comprehensive remote pregnancy monitoring solution comprised of an FDA-cleared wearable sensor band, a patient-facing mobile app (available on iOS and Android), a clinician web portal (INVU Pro), and a proprietary cloud-based data processing platform. The system enables expectant mothers to perform clinically validated non-stress tests (NSTs) and fetal-maternal heart rate monitoring at home or work, with data transmitted to healthcare providers for review. Nuvo also offers an AI-ready longitudinal pregnancy dataset built from INVU monitoring sessions, and the INVU Pro clinician portal enables prescription management, session scheduling, EMR integration, and clinical data review. A recently launched RHTP Application Support Package helps rural providers pursue federal funding for INVU deployment.

Differentiator

Problem solved

Functional benefit

Brands

  • INVU: FDA-cleared remote pregnancy monitoring wearable platform with sensor band, mobile app, and cloud-based data capture and visualization for fetal and maternal health monitoring.
  • INVU Pro

Products and services

  • INVU Wearable Sensor Band FDA-cleared wearable sensor band worn around the expectant mother's belly that captures fetal ECG, fetal phonocardiography, maternal ECG, maternal phonocardiography, and uterine activity data during remote monitoring sessions; provided to expectant mothers via prescription through healthcare providers.
  • INVU Mobile App Patient-facing iOS and Android mobile application that connects to the INVU sensor band via Bluetooth, guides self-administered monitoring sessions, delivers self-guided training, allows patients to chat with support, and access monitoring results and session data.
  • INVU Pro Clinician Portal Web-based portal for healthcare providers to prescribe the INVU system, schedule remote monitoring sessions, review and interpret monitoring data transmitted from patient devices, and integrate session data into the provider's EMR.
  • INVU Cloud Platform Proprietary cloud-based platform that captures, analyzes, and transmits patient data from the INVU sensor band, supports the monitoring workflow for patients and clinicians, stores physiological data in a data lake, and enables integration with EMR systems via Nuvo-supplied APIs.
  • INVU AI-Ready Pregnancy Dataset Large-scale real-world longitudinal dataset of synchronized maternal and fetal physiological signals built from INVU monitoring sessions, combining fetal ECG and phonocardiography with maternal ECG and phonocardiography collected in clinical and home settings; IRB-approved for retrospective analyses and AI model training.

Quantifiable outcome

  • One patient maintained pregnancy from week 32 to week 37 when doctors expected induction at week 34, using remote monitoring instead of hospital admission
  • +2 more outcomes

Companies that use Nuvo Group

Customer profile

Named customers5 records

Segments4 records

Ideal customer profiles3 records

Nuvo Group technology and API

Technology

Technology focussed Yes

API detail

Has API
Yes
API docs
API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability7 records

Feature5 records

Nuvo Group partnerships and signals

Strategic signal

Partnerships

Eight partnerships are on record, tiered core and strategic.

  • TLC PerinatalcoreChannel Partner/ Reseller/ Distributor · 23 March 2026TLC Perinatal, a leading maternal-fetal medicine practice in the DC-Maryland region, adopted INVU for on-demand fetal monitoring. The practice provides pregnant women access to remote non-stress tests connected with their healthcare team for clinical review, supporting high-risk and proactive care.
  • Golden Valley Memorial Healthcare (GVMH)strategicChannel Partner/ Reseller/ Distributor · 16 March 2026Golden Valley Memorial Healthcare deployed INVU to improve maternal health in rural Missouri, addressing the challenge of limited access to obstetric care in maternity care deserts. GVMH is one of the first regional hospitals to deploy this technology to enhance prenatal care for high-risk pregnancies.
  • PhilipsstrategicStrategic or Co-development Partner · 16 September 2025Philips teams up with Nuvo to broaden maternity care access in rural areas with remote monitoring technology, combining Philips' healthcare technology portfolio with Nuvo's INVU platform.
  • MFM AssociatescoreChannel Partner/ Reseller/ Distributor · 15 September 2025Nuvo partnered with MFM Associates to offer remote Non-Stress Tests (NSTs) in New York City, expanding access to INVU monitoring through maternal-fetal medicine specialists.
  • ARC (Sheba Medical Center's Innovation Arm)coreStrategic or Co-development Partner · 24 February 2025ARC and Nuvo are developing advanced AI-driven solutions that enhance clinical decision-making, improve early detection of pregnancy complications, and redefine continuous pregnancy monitoring. The collaboration will create AI-based modules for clinical decision-support tools and population health analysis to improve prenatal care quality.
  • Georgia State UniversitystrategicStrategic or Co-development Partner · 14 December 2023Nuvo partnered with Georgia State University for an NIH-funded multisite study titled 'Advancing understanding of racism-related health disparities beginning before birth.' The study utilizes INVU to research how racism-related stressors impact maternal and fetal health among 400 Black and Latina women in their third trimester.
  • Sheba Medical Center / Sheba BeyondcoreStrategic or Co-development Partner · 11 December 2023Nuvo partnered with Sheba Beyond, one of the world's first virtual hospitals, to transform care for high-risk pregnant patients. The partnership accelerated during wartime Israel to de-hospitalize high-risk inpatients while maintaining exceptional care. Sheba Beyond has been utilizing INVU for over a year to monitor pregnant patients remotely, with benefits including clinical accuracy, resource optimization, and improved patient outcomes.
  • Ouma HealthcoreStrategic or Co-development Partner · 13 December 2022Nuvo and Ouma partnered to deliver the world's first telehealth and remote monitoring solution for pregnancy care. The joint solution combines Ouma's 24/7/365 maternity telehealth clinical services with INVU's FDA-cleared remote fetal surveillance technology to provide equitable access to care, improve preventative care delivery, and reduce costs.

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

Nuvo Group competitors and assessment

Company assessment

Direct peers

  • Bloomlife: Bloomlife develops pregnancy-monitoring wearables that capture uterine and fetal signals for remote, at-home use. It is the closest direct competitor to Nuvo's INVU in the remote fetal-maternal wearable category.
  • HeraMED: HeraMED builds FDA-cleared remote fetal monitoring and pregnancy care solutions including the HeraBEAT handheld Doppler and SaaS maternal health platform. It competes directly with INVU in remote NST and home maternal monitoring.

Broad incumbents

  • Philips: Philips is a global incumbent in maternal-fetal monitoring (e.g., Avalon fetal monitors) and is also an INVU distribution partner. It competes with Nuvo in clinical fetal monitoring and could expand its own wearable roadmap.
  • GE HealthCare: GE HealthCare sells the Giraffe and Corometrics lines of fetal monitors used in hospitals and OB/MFM practices worldwide. It is a broad incumbent serving the same buyer base as INVU with established inpatient monitoring.
  • Mindray: Mindray is a global medical device incumbent with a substantial patient and fetal monitoring portfolio sold into hospitals. It competes with Nuvo at the hospital procurement level even though it does not focus on remote at-home NST.

Emerging players

  • Owlet: Owlet offers FDA-cleared baby monitors (e.g., Dream Sock) that track infant vital signs. While focused on the infant post-birth segment, Owlet competes for the same expectant-parent attention and connected-care wallet.
  • Babyscripts: Babyscripts provides a digital maternity care platform combining remote patient monitoring, education, and risk stratification for payers and providers. It overlaps with Nuvo in the digital maternal RPM space, though its hardware is more limited.
  • Maven Clinic: Maven Clinic operates the largest virtual clinic for women's and family health, offering maternity care programs for employers and payers. It is a partial competitor via telehealth, especially through its overlap with Ouma Health.

Others

  • Oura: Oura sells a consumer smart ring for continuous physiological monitoring (temperature, HR, sleep). It is thematically adjacent as a wearable health-data platform but does not currently monitor fetal signals or compete with INVU clinically.
  • iHealth Labs: iHealth Labs produces connected consumer health devices (BP monitors, glucose meters, thermometers) sold via retail and pharmacy channels. It is an adjacent connected-health hardware player but not a clinical fetal monitoring competitor.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Nuvo Group social profiles

Digital presence

Nuvo Group compliance and trust

Trust signal

Compliance4 records

Nuvo Group financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Nuvo Group leadership team

Management profile

Number of profiles

Profiles8 records

Nuvo Group funding detail

Funding detail

Funding overview

Funding rounds4 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Nuvo Group M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Nuvo Group

What does Nuvo Group do?

Nuvo Group develops and sells the INVU by Nuvo platform, the first and only FDA-cleared wearable system for remote, continuous fetal-maternal monitoring. The platform consists of a proprietary sensor band worn around the expectant mother's belly, a patient-facing mobile app (iOS/Android), the INVU Pro clinician web portal, and a cloud-based data processing platform with EMR integration, enabling pregnant women to perform clinically validated non-stress tests at home or work while clinicians review the data remotely.

Is Nuvo Group a public or private company?

Nuvo Group is a private company. It is classified as public and is currently operating.

When was Nuvo Group founded?

Nuvo Group was founded in 2007. It employs 11 to 50 people.

Where is Nuvo Group based?

Nuvo Group is headquartered in Aventura, United States, in the North America region.

How does Nuvo Group make money?

Three revenue lines are on record. Device Leasing is the primary driver. The others are remote Monitoring Services and data Licensing (Future).

Who are Nuvo Group's main competitors?

Direct peers on record are Bloomlife and HeraMED. Broad incumbents are Philips, GE HealthCare and Mindray. Emerging players are Owlet, Babyscripts and Maven Clinic. Others are Oura and iHealth Labs.

Does Nuvo Group have an API?

Yes. Nuvo allows healthcare providers to connect their Electronic Medical Records (EMR) to the INVU System through one or more APIs supplied by Nuvo. The privacy policy states: 'If you're a Provider, we allow you to connect your electronic medical records ("EMR") to the INVU System through the use of one or more APIs supplied by Nuvo.' No public API documentation, developer portal, SDK, or rate-limit details are provided on the main website. The API is described as an EMR connectivity feature for healthcare providers, not a public or partner-facing developer API.

What industry is Nuvo Group in?

Nuvo Group's product category is Remote Pregnancy Monitoring. Its primary akta.pro industry code is HLAHACAF, Maternal, Fetal & Neonatal Monitoring (CTG, Infant Wearables), with a secondary code of HLACAPAG, Maternal, Neonatal & Pediatric Remote Monitoring. Its NAICS code is 339113 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
AijournNuvo Launches RHTP Application Support for Rural Providers Seeking Maternity Care FundingNuvo Intl Group Inc. announced the launch of an RHTP application support package to help rural hospitals, clinics, and OB practices pursue federal funding for its FDA-cleared INVU™ remote pregnancy monitoring technology. The support package, offered ahead of the October 30, 2026 RHTP commitment deadline, includes clinical evidence files, procurement materials, budget templates, and state-specific eligibility guidance. The $50 billion Rural Health Transformation Program has identified maternity care as a key priority, and Nuvo aims to remove administrative barriers preventing rural providers from accessing funds to expand at-home fetal monitoring services in underserved communities.HIT ConsultantSheba and Nuvo Partner to Deploy AI-Driven Pregnancy MonitoringSheba Medical Center and Nuvo Group are partnering to develop AI-powered prenatal monitoring tools. The collaboration, facilitated by ARC, aims to enhance early detection of complications and improve maternal and fetal outcomes. It also plans to integrate AI with Nuvo's remote monitoring solutions.GlobeNewswireNuvo Group Adds HealthTech Veteran Adriana Machado to Board of Directors, Strengthening Company’s Commitment to Transforming Prenatal CareNuvo Group added Adriana Machado to its board of directors, bringing three decades of business leadership experience. The company plans to expand sales in the US and Israel and introduce its INVU platform in Europe in 2024, subject to CE mark approval.GlobeNewswireNuvo Group Adds HealthTech Veteran Adriana Machado to Board of Directors, Strengthening Company’s Commitment to Transforming Prenatal CareNuvo Group added Adriana Machado to its board of directors, bringing three decades of business leadership experience. The company plans to expand sales in the US and Israel and introduce its INVU platform in Europe in 2024, pending CE mark approval.Business InsiderNuvo Group Adds HealthTech Veteran Adriana Machado to Board of Directors, Strengthening Company’s Commitment to Transforming Prenatal CareNuvo Group added Adriana Machado to its board of directors, bringing three decades of business leadership experience. The company plans to expand sales in the US and Israel and introduce its INVU platform in Europe in 2024, pending CE mark approval.PR NewswireRemote Pregnancy Care Innovator Nuvo Group Ltd. Becomes Public Company Through Completion of Business Combination with LAMF Global Ventures Corp.Nuvo Group completed its business combination with LAMF Global Ventures Corp., becoming a public company on NASDAQ under ticker NUVO as of May 2, 2024. The combined company will retain Nuvo's name and leadership, with CEO Rice Powell. Nuvo plans to expand sales in the US and Israel and introduce its INVU platform in Europe in 2024.PR NewswireNuvo Group Ltd., a Leading Innovator in Pregnancy Care, Nears Closure of Business Combination with LAMF Global Ventures Corp. INuvo Group Ltd. announced that its business combination with special purpose acquisition company LAMF Global Ventures Corp. I is expected to close on or about May 1, 2024. The merger will enable Nuvo to access capital markets for commercial growth and international expansion, with shares expected to begin trading under the ticker "NUVO" on Nasdaq around May 2, 2024. This transaction follows shareholder approval in April and aims to accelerate the deployment of Nuvo's remote pregnancy monitoring platform.PR NewswireLAMF Global Ventures Corp. I Announces Sixth Extension of Deadline to Complete Initial Business CombinationLAMF Global Ventures Corp. I, a special purpose acquisition company listed on Nasdaq, has announced its sixth extension of the deadline to complete an initial business combination, pushing the deadline from April 16, 2024 to May 16, 2024. The extension is intended to facilitate the closing of a business combination agreement dated August 17, 2023, involving Israeli company Nuvo Group Ltd. and two subsidiary entities. This is the final one-month extension available to the company under its amended and restated memorandum and articles of association.PR NewswireLAMF Global Ventures Corp. I Announces Intent to Adjourn Extraordinary General Meeting of Shareholders Until April 1, 2024LAMF Global Ventures Corp. I announced it will adjourn its extraordinary general meeting of shareholders from March 28, 2024 to April 1, 2024, without conducting any business at the original scheduled time. The adjournment is intended to give shareholders time to review a prospectus supplement related to the proposed business combination with Nuvo Group Ltd. and its affiliated entities. No changes have been made to the proposals that shareholders will vote on at the postponed meeting.CircuitNuvo, a maker of remote fetal monitors, prepares for Wall Street debutNuvo Group, a maker of remote fetal monitors, is preparing for a Nasdaq debut via a SPAC merger, aiming to raise at least $30 million. The company's INVU device, approved by the FDA for remote heart-rate and non-stress testing, has a distribution agreement with Philips. Nuvo plans to sell the system first in the U.S., Europe, and Israel.